4//SEC Filing
FIBROGEN INC 4
Accession 0001209191-16-100020
$FGENCIK 0000921299operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:17 PM ET
Size
13.3 KB
Accession
0001209191-16-100020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
VALONE FRANK H MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-02-16$2.90/sh+2,492$7,227→ 99,332 total - Exercise/Conversion
Common Stock
2016-02-16$3.50/sh+8,258$28,903→ 107,590 total - Sale
Common Stock
2016-02-16$18.41/sh−10,750$197,943→ 96,840 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-02-16−8,258→ 31,742 totalExercise: $3.50Exp: 2021-06-07→ Common Stock (8,258 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2016-02-16−2,492→ 7,508 totalExercise: $2.90Exp: 2020-06-09→ Common Stock (2,492 underlying)
Holdings
- 4,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices between $18.0122 and $18.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Twenty percent of the shares subject to each option vests on the first anniversary of the vesting commencement date and 80% of the shares subject to each option vests in 16 substantially equal quarterly installments thereafter over for the following four years.
- [F4]Fully vested.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000921299
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:17 PM ET
- Size
- 13.3 KB